Earnings ·
Danaher Corporation reported second quarter 2026 results with net earnings of $870 million, or $1.23 per diluted…
DHRDanaher Corp
Danaher Corporation reported second quarter 2026 results with net earnings of $870 million, or $1.23 per diluted common share, representing a 60% year-over-year increase. Revenues rose 5.5% to $6.3 billion. Non-GAAP adjusted diluted net earnings per share grew 8.0% to $1.94. Operating cash flow reached $1.5 billion, while non-GAAP free cash flow was $1.3 billion. Following the earlier-than-anticipated completion of the Masimo acquisition, the company raised its full year 2026 adjusted diluted net earnings per share guidance to a range of $8.45 to $8.60. Danaher also announced its intention to acquire StatLab, a histology workflow manufacturer, by the end of 2026. Danaher is a global life sciences and diagnostics company.